Cargando…
In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis
BACKGROUND: Alpha-synuclein (ASYN) is central in Parkinson’s disease (PD) pathogenesis. Converging pieces of evidence suggest that the levels of ASYN expression play a critical role in both familial and sporadic Parkinson’s disease. ASYN fibrils are the main component of inclusions called Lewy Bodie...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062111/ https://www.ncbi.nlm.nih.gov/pubmed/24885905 http://dx.doi.org/10.1186/1752-0509-8-54 |
_version_ | 1782321591998218240 |
---|---|
author | Ouzounoglou, Eleftherios Kalamatianos, Dimitrios Emmanouilidou, Evangelia Xilouri, Maria Stefanis, Leonidas Vekrellis, Kostas Manolakos, Elias S |
author_facet | Ouzounoglou, Eleftherios Kalamatianos, Dimitrios Emmanouilidou, Evangelia Xilouri, Maria Stefanis, Leonidas Vekrellis, Kostas Manolakos, Elias S |
author_sort | Ouzounoglou, Eleftherios |
collection | PubMed |
description | BACKGROUND: Alpha-synuclein (ASYN) is central in Parkinson’s disease (PD) pathogenesis. Converging pieces of evidence suggest that the levels of ASYN expression play a critical role in both familial and sporadic Parkinson’s disease. ASYN fibrils are the main component of inclusions called Lewy Bodies (LBs) which are found mainly in the surviving neurons of the substantia nigra. Despite the accumulated knowledge regarding the involvement of ASYN in molecular mechanisms underlying the development of PD, there is much information missing which prevents understanding the causes of the disease and how to stop its progression. RESULTS: Using a Systems Biology approach, we develop a biomolecular reactions model that describes the intracellular ASYN dynamics in relation to overexpression, post-translational modification, oligomerization and degradation of the protein. Especially for the proteolysis of ASYN, the model takes into account the biological knowledge regarding the contribution of Chaperone Mediated Autophagy (CMA), macro-autophagic and proteasome pathways in the protein’s degradation. Importantly, inhibitory phenomena, caused by ASYN, concerning CMA (more specifically the lysosomal-associated membrane protein 2a, abbreviated as Lamp2a receptor, which is the rate limiting step of CMA) and the proteasome are carefully modeled. The model is validated by simulation studies of known experimental overexpression data from SH-SY5Y cells and the unknown model parameters are estimated either computationally or by experimental fitting. The calibrated model is then tested under three hypothetical intervention scenarios and in all cases predicts increased cell viability that agrees with experimental evidence. The biomodel has been annotated and is made available in SBML format. CONCLUSIONS: The mathematical model presented here successfully simulates the dynamic phenomena of ASYN overexpression and oligomerization and predicts the biological system’s behavior in a number of scenarios not used for model calibration. It allows, for the first time, to qualitatively estimate the protein levels that are capable of deregulating proteolytic homeostasis. In addition, it can help form new hypotheses for intervention that could be tested experimentally. |
format | Online Article Text |
id | pubmed-4062111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40621112014-06-27 In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis Ouzounoglou, Eleftherios Kalamatianos, Dimitrios Emmanouilidou, Evangelia Xilouri, Maria Stefanis, Leonidas Vekrellis, Kostas Manolakos, Elias S BMC Syst Biol Research Article BACKGROUND: Alpha-synuclein (ASYN) is central in Parkinson’s disease (PD) pathogenesis. Converging pieces of evidence suggest that the levels of ASYN expression play a critical role in both familial and sporadic Parkinson’s disease. ASYN fibrils are the main component of inclusions called Lewy Bodies (LBs) which are found mainly in the surviving neurons of the substantia nigra. Despite the accumulated knowledge regarding the involvement of ASYN in molecular mechanisms underlying the development of PD, there is much information missing which prevents understanding the causes of the disease and how to stop its progression. RESULTS: Using a Systems Biology approach, we develop a biomolecular reactions model that describes the intracellular ASYN dynamics in relation to overexpression, post-translational modification, oligomerization and degradation of the protein. Especially for the proteolysis of ASYN, the model takes into account the biological knowledge regarding the contribution of Chaperone Mediated Autophagy (CMA), macro-autophagic and proteasome pathways in the protein’s degradation. Importantly, inhibitory phenomena, caused by ASYN, concerning CMA (more specifically the lysosomal-associated membrane protein 2a, abbreviated as Lamp2a receptor, which is the rate limiting step of CMA) and the proteasome are carefully modeled. The model is validated by simulation studies of known experimental overexpression data from SH-SY5Y cells and the unknown model parameters are estimated either computationally or by experimental fitting. The calibrated model is then tested under three hypothetical intervention scenarios and in all cases predicts increased cell viability that agrees with experimental evidence. The biomodel has been annotated and is made available in SBML format. CONCLUSIONS: The mathematical model presented here successfully simulates the dynamic phenomena of ASYN overexpression and oligomerization and predicts the biological system’s behavior in a number of scenarios not used for model calibration. It allows, for the first time, to qualitatively estimate the protein levels that are capable of deregulating proteolytic homeostasis. In addition, it can help form new hypotheses for intervention that could be tested experimentally. BioMed Central 2014-05-13 /pmc/articles/PMC4062111/ /pubmed/24885905 http://dx.doi.org/10.1186/1752-0509-8-54 Text en Copyright © 2014 Ouzounoglou et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article Ouzounoglou, Eleftherios Kalamatianos, Dimitrios Emmanouilidou, Evangelia Xilouri, Maria Stefanis, Leonidas Vekrellis, Kostas Manolakos, Elias S In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis |
title | In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis |
title_full | In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis |
title_fullStr | In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis |
title_full_unstemmed | In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis |
title_short | In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis |
title_sort | in silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062111/ https://www.ncbi.nlm.nih.gov/pubmed/24885905 http://dx.doi.org/10.1186/1752-0509-8-54 |
work_keys_str_mv | AT ouzounogloueleftherios insilicomodelingoftheeffectsofalphasynucleinoligomerizationondopaminergicneuronalhomeostasis AT kalamatianosdimitrios insilicomodelingoftheeffectsofalphasynucleinoligomerizationondopaminergicneuronalhomeostasis AT emmanouilidouevangelia insilicomodelingoftheeffectsofalphasynucleinoligomerizationondopaminergicneuronalhomeostasis AT xilourimaria insilicomodelingoftheeffectsofalphasynucleinoligomerizationondopaminergicneuronalhomeostasis AT stefanisleonidas insilicomodelingoftheeffectsofalphasynucleinoligomerizationondopaminergicneuronalhomeostasis AT vekrelliskostas insilicomodelingoftheeffectsofalphasynucleinoligomerizationondopaminergicneuronalhomeostasis AT manolakoseliass insilicomodelingoftheeffectsofalphasynucleinoligomerizationondopaminergicneuronalhomeostasis |